本文报道环孢菌素(CS)及秋水仙碱(CC)治疗白塞氏病的双盲研究结果,以及长程使用 CS的效果与安全性。受试对象为96例,年龄在15岁以上的完全型或不完全型白塞氏病患者,其视力均低于20/40,且于受试前16周至少出现2次眼部症状。47例服用 CS,49例服 CC。研究前两组性别、年龄、眼受累的程度、病程、并发症、研究前眼病发作次数、视力及治疗情况等均无显著差异。采用双 This article reports the results of a double-blind study of cyclosporine (CS) and colchicine (CC) in the treatment of Behcet’s disease, as well as the efficacy and safety of long-term CS. Subjects were 96 subjects with complete or incomplete Behcet’s disease who were over 15 years of age with a visual acuity of less than 20/40 and at least two ocular symptoms 16 weeks prior to the test. 47 patients taking CS, 49 patients with CC. The first two groups of gender, age, degree of eye involvement, duration, complications, study the number of pre-ophthalmic attacks, visual acuity and treatment were no significant differences. Double